|Day Low/High||33.40 / 34.55|
|52 Wk Low/High||14.81 / 45.60|
Doug Kass shares his views on why technicals bode ill for tech.
Conference Call Today at 8:30 a.m. ET
--Target FDA Action Date is August 17, 2016--
Doug Kass shares his views on the health of the banking sector and why he's buying biotech.
Portola Retains Full Worldwide Commercial Rights to Andexanet Alfa Outside of Japan
Two Products in Thrombosis Franchise Expected to Launch in Next 18 Months
These stocks look poised to break out and trade higher from current levels.
Full Data Set From ANNEXA-R Also Presented Today in Late-Breaking Clinical Trial Session at AHA Scientific Sessions 2015
Full Results of Andexanet Alfa and Rivaroxaban Part 2 Study to be Featured in Late-Breaking Clinical Trial Oral Session on November 11th
Betrixaban Has Potential to Become First Oral Factor Xa Inhibitor Anticoagulant Approved for Hospital-to-Home Prevention of Venous Thromboembolism in Acute Medically Ill Patients
Trade-Ideas LLC identified Portola Pharmaceuticals (PTLA) as a "perilous reversal" (up big yesterday but down big today) candidate
Trade-Ideas LLC identified Portola Pharmaceuticals (PTLA) as a new lifetime high candidate
New Topline Data From Pivotal Study Demonstrate Sustained Reversal of Anticoagulant Effect of Factor Xa Inhibitor Rivaroxaban Following Administration of Portola's FDA-Designated Breakthrough Therapy
Pharmaceutical stocks were not immune to the recent market selloff, presenting buying opportunities for investors. Here are eight companies with upcoming events to drive their stocks even higher.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.